Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal
Sign Up to like & getrecommendations! Published in 2018 at "Therapeutics and Clinical Risk Management"
DOI: 10.2147/tcrm.s140377
Abstract: Use of non-vitamin K antagonist oral anticoagulants is spreading in the real world. Despite that, a strong need for antidotes/reversal agents is still reported by several physicians. Idarucizumab is a humanized monoclonal antibody fragment that… read more here.
Keywords: use; use idarucizumab; idarucizumab reversing; reversing dabigatran ... See more keywords